What's the wisdom of Allah in these testing times??
A session by Daee Ahmed Moait covering topics:
- The Ummah in tribulations ..
- The Mercy taught to us by our teacher, Muhammad SAW
- Sanctity of a soul ...
- are the animals and beasts laughing at us??
- Verses from Qur'an about the hypocrites and the people who are veiled
- trials to some, Mercy to some...
What's the wisdom of Allah in these testing times??
A session by Daee Ahmed Moait covering topics:
- The Ummah in tribulations ..
- The Mercy taught to us by our teacher, Muhammad SAW
- Sanctity of a soul ...
- are the animals and beasts laughing at us??
- Verses from Qur'an about the hypocrites and the people who are veiled
- trials to some, Mercy to some...
What's the wisdom of Allah in these testing times??
A session by Daee Ahmed Moait covering topics:
- The Ummah in tribulations ..
- The Mercy taught to us by our teacher, Muhammad SAW
- Sanctity of a soul ...
- are the animals and beasts laughing at us??
- Verses from Qur'an about the hypocrites and the people who are veiled
- trials to some, Mercy to some...
As infants they were smuggled out of a cult by their aunt. Their mother was murdered by the cult leader, their father. In hiding, Ivy and her twin sister Amber are taught how to fight. How to stay alive. But at 16 some of life’s trials are unexpected. Like love. And the ability to heal with a touch. When her father kidnaps their adoptive parents and forces them to come to the cult compound, Ivy makes a mistake with her power that ends in tragedy, and brings about her sister’s unusual power with the dead. Find out more at http://www.SheilaEnglish.com Keeper of the Light Book 1 of The Faith Healer’s Daughters trilogy. Paranormal/fantasy
Zensun Sci & Tech, Ltd., a biopharmaceutical company based in Shanghai and San Diego, announced today positive results of four completed Phase 2 clinical trials including three double-blind, placebo-controlled studies conducted in China and Australia and interim results from the United States Phase 2 trial for Zensun’s innovative “first-in-class” anti-heart failure drug, Neucardin™.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61677-zensun-completes-clinical-trials-of-neucardin-treatment-of-heart-failure
Let’s Win, an initiative supported by the Lustgarten Foundation, launched the Let’s Win! Pancreatic Cancer Survivors video series Friday, January 19, 2018, at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium. The new online video series, featuring long-term pancreatic cancer survivors of all ages and diverse backgrounds, has been created to show pancreatic cancer patients and their families that people do survive this disease. The survivors have responded exceptionally well to pancreatic cancer therapy that incorporates clinical trials and treatments that go beyond traditional protocols.
When patients are first diagnosed with pancreatic cancer, they often turn to the internet, only to find devastating and frightening statistics about the disease. “Our goal is to provide hope and inspiration to patients and their families,” says Cindy Gavin, founding executive director of Let’s Win. “We are so grateful for the incredible vision of one special patient and the generosity of The Flora Family Foundation for their support of this incredible initiative.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8213752-lets-win-pancreatic-cancer-survivor-video-series/
In recent years there has been a shift in the understanding of cancer. Immunotherapy with vaccines has been emerging as the most promising direction towards a decisive improvement of treatment outcomes.
The Dendritic Cell Vaccine has received FDA approval for prostate cancer and trials are now under way for a variety of other cancers. These vaccines are usually administered on their own.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64654-issels-integrative-immunotherapy-for-standard-therapy-resistant-cancers
After nearly eight years of careful planning, guests from across Illinois gathered today in Lake Forest to celebrate the ceremonial opening of the new Northwestern Medicine Lake Forest Hospital, which will officially open on March 3, 2018.
The new state-of-the-art hospital, which broke ground in 2014, will provide patients convenient access to world-class physicians with seamless access to Northwestern Memorial Hospital, Illinois’s premier academic medical center when needed. The new Lake Forest Hospital will offer cutting-edge treatments and innovative clinical trials within a world class health system.
To view the multimedia release go to:
https://www.multivu.com/players/English/8213351-new-northwestern-medicine-lake-forest-hospital/
Combining their expertise in clinical trials support and cellular therapies, BloodCenter of Wisconsin (BCW) and the San Diego Blood Bank (SDBB) have created a strategic partnership to accelerate advancements in research and patient care. Together, BloodCenter of Wisconsin and San Diego Blood Bank will offer Celluvative™ – a portfolio of products and clinical trial services that will include esoteric laboratory testing, blood products for research and manufacturing applications, cell processing, and access to a broad database of diverse donors who have expressed interest in clinical trials.
“Through the strength of our partnership, we are able to offer end-to-end services to academic organizations, research institutions and other industry partners who are working to develop novel cellular therapy approaches,” said Matthew Anderson, M.D., Ph.D., medical director, BloodCenter of Wisconsin Diagnostic Laboratories. “Among other offerings, our Celluvative portfolio enables access to an extremely diverse donor database – an invaluable resource to enable advances in the area of regenerative medicine and drug discovery.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7855451-bloodcenter-sdbb-celluvative/
